142 related articles for article (PubMed ID: 20930380)
1. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Kase Y; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(10):1710-5. PubMed ID: 20930380
[TBL] [Abstract][Full Text] [Related]
2. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
Sadakane C; Kase Y; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
[TBL] [Abstract][Full Text] [Related]
3. TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(8):1349-54. PubMed ID: 20686230
[TBL] [Abstract][Full Text] [Related]
4. (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2010 Dec; 14(6):528-35. PubMed ID: 20814808
[TBL] [Abstract][Full Text] [Related]
5. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
Sadakane C; Hattori T; Koseki J; Inagaki Y; Hasegawa Y; Shindo S; Takeda S; Takeda H
Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
7. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
8. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.
Datta PK; Reddy RS; Lianos EA
Inflammation; 2001 Dec; 25(6):351-9. PubMed ID: 11831438
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
10. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
[TBL] [Abstract][Full Text] [Related]
11. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
12. Tranilast ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kelly DJ; Cox A; Zhang Y; Thai K; Nikolic-Paterson DJ; Gilbert RE
Nephron Exp Nephrol; 2008; 109(1):e1-7. PubMed ID: 18480612
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
15. DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Isaka Y; Nakamura H; Mizui M; Takabatake Y; Horio M; Kawachi H; Shimizu F; Imai E; Hori M
Kidney Int; 2004 Aug; 66(2):586-90. PubMed ID: 15253710
[TBL] [Abstract][Full Text] [Related]
16. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
17. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
18. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
Peters H; Eisenberg R; Daig U; Liefeldt L; Westenfeld R; Gaedeke J; Krämer S; Neumayer HH
Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
[TBL] [Abstract][Full Text] [Related]
19. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta.
Schneider A; Thaiss F; Rau HP; Wolf G; Zahner G; Jocks T; Helmchen U; Stahl RA
Kidney Int; 1996 Jul; 50(1):190-9. PubMed ID: 8807588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
